Exclusives Archives - Page 40 of 102

2 minute read

EXCLUSIVE: Shiba Inu’s Lead Developer Highlights Fusion Of Virtual And Physical Realms

September 8, 2:58 PM

In the evolving intersection of virtual communities and real-world businesses, Shytoshi Kusama, the lead developer of Shiba Inu (CRYPTO: SHIB), has highlighted the transformative

$SHIB

2 minute read

Exclusive: Bit2Me And droppGroup Seal Game-Changing Web3 Global Partnership

By Javier Hasse

September 8, 1:24 PM

Bit2Me and droppGroup, two stalwarts in the Web3 technology sector, have officially cemented a strategic partnership, marking a pivotal advancement in the global Web3 ecosystem.

3 minute read

EXCLUSIVE: Gary Vee Predicts NY Jets’ Playoff Return In 2023, ‘I Know My Team’ – Betting Odds Revealed

By Chris Katje

September 8, 12:51 PM

Serial entrepreneur Gary Vee is known for many things and has investments in sports like pickleball, BIG3 basketball and Slamball. Vee's fans are well aware that his deepest sports love is for the New York Jets, a team he hopes to buy one day. In a conversation with Benzinga, Vee gave his predictions for the New York Jets' 2023 NFL season outcome.

AMZN

6 minute read

EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With ‘Unique, But Pretty Simple’ Drug

By Shanthi Rexaline

September 8, 8:42 AM

Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.

CALT

1 minute read

EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers

By Vandana Singh

September 8, 6:30 AM

Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal flu

BIOC

2 minute read

EXCLUSIVE: Is Cathie Wood Using ChatGPT To Pick Stocks?

By AJ Fabino

September 7, 12:19 PM

Most investors know that Ark Invest founder Cathie Wood’s investment style is to consistently bet on disruptive innovation:…

NVDA

2 minute read

Breaking: High Times To Go Public Via Deal With Nasdaq-Listed Lucy Scientific

By Javier Hasse

September 7, 8:30 AM

High Times Holding Corp., a touchstone in the cannabis culture for nearly five decades, announced a landmark transaction with Lucy Scientific Discovery Inc. (NASDAQ: LSDI) that would finally make the iconic brand publicly traded. The deal involves a divestment of co

CGC

2 minute read

Trulieve CEO: Federal Rescheduling Could Change Heavy Tax Burden For Cannabis Industry

By Joana Scopel

September 6, 4:27 PM

"It's not if, it's just when," said Kim Rivers, CEO of Trulieve Cannabis Corp (OTCQX: TCNNF), regarding the recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administration (DEA) regarding the

TCNNF

2 minute read

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

By Vandana Singh

September 6, 7:40 AM

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:

ERNA

3 minute read

EXCLUSIVE: Curaleaf Chairman Predicts DEA’s Future Steps On Cannabis Rescheduling

By Joana Scopel

September 5, 6:23 PM

"This is a big deal," says Boris Jordan, founder and executive chairman of the board of Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), referring to the recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administ

CSE:CURA